Follow-The-Filings

Security

HALO

Halozyme Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

16 owners 1 new max 0.4% (Torray Investment Partner...)

grid → activity →
owners 16
max % 0.4%
tracked value $1.4B
qoq N 1 A 5 R 7

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Torray Investment Partners LLC 2026 Q2 stale 0.4% Add +0.05 pp 38,703 $3M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.2% Add +0.04 pp 746,841 $48M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.2% Reduce +0.01 pp 511,429 $33M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.1% Add +0.01 pp 1,868,708 $121M hist
Two Sigma Investments, LP 2025 Q4 stale 0.1% Exit -0.07 pp 717,369 $48M hist
Renaissance Technologies LLC 2026 Q1 0.1% Add +0.02 pp 731,811 $47M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce -0.01 pp 1,016,429 $65M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 11,566,896 $778M hist
Norges Bank 2025 Q4 stale 0.0% Exit -0.01 pp 1,904,922 $128M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce -0.03 pp 471,284 $30M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Reduce 0.00 pp 444,689 $29M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce -0.02 pp 121,006 $8M hist
Natixis Advisors, LLC 2026 Q1 0.0% Add 0.00 pp 106,305 $7M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% New 0.0% 191,051 $12M hist
Richard Pzena - Pzena Investment Management LLC 2026 Q1 0.0% Reduce 0.00 pp 4,049 $262 hist
Ancora Advisors LLC 2026 Q1 0.0% — 113 $7 hist

16 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $829.25M $1.02B $1.4B
Gross profit * $636.89M $855.91M $1.17B
Gross margin * 76.8% 84.3% 83.6%
Net income $281.59M $444.09M $316.89M
Net margin * 34.0% 43.7% 22.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $746.42M $1.09B $825.21M
Total non-current assets * $986.85M $978.14M $1.7B
Total assets $1.73B $2.06B $2.53B
Total current liabilities $112.49M $139.1M $177.09M
Total non-current liabilities * $1.54B $1.56B $2.3B
Total equity $83.81M $363.82M $48.81M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $388.57M $479.06M $651.56M
Cash from investing -$96.91M -$262.72M -$545.81M
Cash from financing -$407.99M -$218.86M -$85.17M
Net change in cash -$116.32M -$2.52M $20.57M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders